Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics.
Serotonin S2 and dopamine D2 receptors in the prefrontal cortex and caudate nucleus of postmortem brains of chronic schizophrenics were studied using 3H-ketanserin and 3H-spiperone, respectively. In the prefrontal cortex of schizophrenics, we found a significant decrease in the maximum number of 3H-ketanserin binding sites (Bmax), with no change in the dissociation constant (Kd). Conversely, both Bmax and Kd of 3H-spiperone binding to the caudate nucleus were significantly increased in the schizophrenic patients. There were no differences in receptor indices between patients who were taking neuroleptics until their death and those who had taken none for 2 months or more prior to death. These findings suggest that alterations in S2 receptors in the prefrontal cortex may reflect the disease process, per se, and that the increase in the number of D2 receptors in the caudate nucleus of schizophrenics is not due solely to neuroleptic medication.
D000328:Adult; D000368:Aged; D002421:Caudate Nucleus / Q000032:analysis*; D002908:Chronic Disease; D005260:Female; D005625:Frontal Lobe / Q000032:analysis*; D006801:Humans; D007650:Ketanserin / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D011869:Radioligand Assay; D011954:Receptors, Dopamine / Q000032:analysis*; D017448:Receptors, Dopamine D2; D011985:Receptors, Serotonin / Q000032:analysis*; D012559:Schizophrenia / Q000378:metabolism*; D013134:Spiperone / Q000378:metabolism
D011954:Receptors, Dopamine; D017448:Receptors, Dopamine D2; D011985:Receptors, Serotonin; D013134:Spiperone; D007650:Ketanserin